bimekizumab
ucb pharmaceuticals
['bimekizumab', ' psa']
#spa #abstracts #acr22 1599. bimekizumab in pts with active psa &amp; inadequate response to tnfi: 16-w efficacy and safety
ph 3rct clinically meaningful and stat significant improvements in efficacy outcomes vs pbo no new safety signals were observed #acrambassador 
Rheumatologist | Epi | ASAS | Twitter Ambassador (ACR/ ARD-BMJ) | ArLAR ARCH President | St Joseph University & HDF Beirut | Love Music | Travel Books